General Information
|
|
Product
|
PrLZ / TPD52 Peptide
|
Description
|
Antigenic Blocking Peptide Prostate leucine zipper isoform 5 C-epitope
|
Verified Applications
|
Immunocompeition, Immunodepletion
|
Peptide Description
|
Synthetic peptide taken within amino acid region 101-151 on human Prostate leucine zipper isoform 5 protein.
|
Accession #
|
NCBI: NP_001020423.1
|
Physical Properties
|
|
Quantity
|
250 µg
|
Volume
|
100 µl
|
Form
|
Antigenic Blocking Peptide
|
Determinant
|
C-epitope
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
Protein
|
Uniprot #
|
P55327
|
Molecular Function
|
calcium ion binding, protein heterodimerization activity, protein homodimerization activity
|
Subcellular Location
|
cytoplasm, perinuclear region of cytoplasm, endoplasmic reticulum
|
Expression
|
Isoform 2 is expressed in colon, breast, prostate, pancreas and kidney tumor cell lines. Isoform 2 is expressed at high levels in kidney, prostate, brain, small intestine and pancreas, at moderate levels in placenta and colon, at low levels in lung, liver and at very low levels in spleen, thymus, peripheral mononuclear blood cells, testis and ovary.
|
Structure
|
Forms a homodimer or heterodimer with other members of the family. All isoforms interact with several 14-3-3 proteins.
|
Alternative Nomenclature
|
D52 antibody
Human 19.8 kDa protein mRNA, complete cds antibody
N8L antibody
PC 1 antibody
PC1/MRPS28 fusion protein antibody
PrLZ antibody
Prostate and colon associated protein antibody
Prostate leucine zipper antibody
Protein N8 antibody
TPD52 antibody
Tumor protein D52 antibody
|
|
|